Literature DB >> 2904271

The catalepsy test: its ups and downs.

P R Sanberg1, M D Bunsey, M Giordano, A B Norman.   

Abstract

The typical catalepsy test consists of placing an animal into an unusual posture and recording the time taken to correct this posture. This time is regarded as an index of the intensity of catalepsy. Catalepsy is a robust behavior, and the lack of standardization does not usually hinder its actual detection. However, the intensity of the cataleptic effect is influenced by minor methodological differences, and thus interpretation and comparison of results across laboratories are difficult. The behavioral catalepsy test can use any of several different apparatus, including wire grids, parallel bars, platforms, or pegs, to situate the animals in unusual positions. The most common, however, is the "bar test," and despite its wide use in psychopharmacological research, even parameters of this test are not standardized. The present article reviews the wide variety of parameters chosen by investigators that measure catalepsy. The methodological issues of repeated testing, scaling of scores, apparatus, animal weight, maximal test duration, behavioral criteria, and other influences are discussed. In addition, a brief review of the neuropharmacological basis of catalepsy is also included. Finally, it is argued that a universal, standardized bar test be adopted by researchers. New data on a novel automated bar test in the Digiscan Activity Monitoring System is presented.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904271     DOI: 10.1037//0735-7044.102.5.748

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  74 in total

1.  Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo.

Authors:  Zhen-tao Zhang; Xue-bing Cao; Nian Xiong; Hong-cai Wang; Jin-sha Huang; Sheng-gang Sun; Tao Wang
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

2.  Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.

Authors:  Cynthia A Kelm-Nelson; Katie M Yang; Michelle R Ciucci
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

3.  2',3'-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease.

Authors:  Jianyi Niu; Jing Xiong; Dan Hu; Fei Zeng; Shuke Nie; Shanping Mao; Tao Wang; Zhentao Zhang; Zhaohui Zhang
Journal:  Neurochem Res       Date:  2017-06-19       Impact factor: 3.996

4.  Effects of experimental increases and decreases in thyroxine levels on the extent of cataleptic freezing reactions in rats.

Authors:  A V Kulikov; M A Tikhonova; E I Lebedeva; V F Chugui; N K Popova
Journal:  Neurosci Behav Physiol       Date:  2005-09

5.  Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.

Authors:  Darryl T Hamamoto; Subhalakshmi Giridharagopalan; Donald A Simone
Journal:  Eur J Pharmacol       Date:  2006-12-09       Impact factor: 4.432

6.  Brain disposition and catalepsy after intranasal delivery of loxapine: role of metabolism in PK/PD of intranasal CNS drugs.

Authors:  Yin Cheong Wong; Zhong Zuo
Journal:  Pharm Res       Date:  2013-06-07       Impact factor: 4.200

7.  Chlorpyrifos Exposure Induces Parkinsonian Symptoms and Associated Bone Loss in Adult Swiss Albino Mice.

Authors:  Shaheen Jafri Ali; Govindraj Ellur; Kalpana Patel; Kunal Sharan
Journal:  Neurotox Res       Date:  2019-07-31       Impact factor: 3.911

8.  Burst activity of spiny projection neurons in the striatum encodes superimposed muscle tetani in cataleptic rats.

Authors:  Stefanie Th Frank; Werner J Schmidt
Journal:  Exp Brain Res       Date:  2003-08-30       Impact factor: 1.972

9.  Reversal of established traumatic brain injury-induced, anxiety-like behavior in rats after delayed, post-injury neuroimmune suppression.

Authors:  Krista M Rodgers; Yuetiva K Deming; Florencia M Bercum; Serhiy Y Chumachenko; Julie L Wieseler; Kirk W Johnson; Linda R Watkins; Daniel S Barth
Journal:  J Neurotrauma       Date:  2013-11-20       Impact factor: 5.269

10.  Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats.

Authors:  Santhrani Thaakur; G Himabindhu
Journal:  J Neural Transm (Vienna)       Date:  2009-05-15       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.